182 related articles for article (PubMed ID: 19966852)
21. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.
Tatetsu H; Ueno S; Hata H; Yamada Y; Takeya M; Mitsuya H; Tenen DG; Okuno Y
Cancer Res; 2007 Jun; 67(11):5328-36. PubMed ID: 17545613
[TBL] [Abstract][Full Text] [Related]
23. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB.
Cleynen I; Brants JR; Peeters K; Deckers R; Debiec-Rychter M; Sciot R; Van de Ven WJ; Petit MM
Mol Cancer Res; 2007 Apr; 5(4):363-72. PubMed ID: 17426251
[TBL] [Abstract][Full Text] [Related]
24. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription.
Brown NL; Finnon R; Bulman RA; Finnon P; Moody J; Bouffler SD; Badie C
Leuk Res; 2011 Jan; 35(1):126-32. PubMed ID: 20638124
[TBL] [Abstract][Full Text] [Related]
25. Complexity of miR-223 regulation by CEBPA in human AML.
Eyholzer M; Schmid S; Schardt JA; Haefliger S; Mueller BU; Pabst T
Leuk Res; 2010 May; 34(5):672-6. PubMed ID: 20018373
[TBL] [Abstract][Full Text] [Related]
26. GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia.
Burda P; Vargova J; Curik N; Salek C; Papadopoulos GL; Strouboulis J; Stopka T
PLoS One; 2016; 11(3):e0152234. PubMed ID: 27010793
[TBL] [Abstract][Full Text] [Related]
27. Heterozygous deletion of the PU.1 locus in human AML.
Bonadies N; Pabst T; Mueller BU
Blood; 2010 Jan; 115(2):331-4. PubMed ID: 19890096
[TBL] [Abstract][Full Text] [Related]
28. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
Linderson Y; French NS; Neurath MF; Pettersson S
Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
[TBL] [Abstract][Full Text] [Related]
29. Human monocyte/neutrophil elastase inhibitor (MNEI) is regulated by PU.1/Spi-1, Sp1, and NF-kappaB.
Zeng W; Remold-O'Donnell E
J Cell Biochem; 2000 Jun; 78(4):519-32. PubMed ID: 10861849
[TBL] [Abstract][Full Text] [Related]
30. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
31. The actin-binding protein CORO1A is a novel PU.1 (SPI1)- and CEBPA-regulated gene with significantly lower expression in APL and CEBPA-mutated AML patients.
Federzoni EA; Humbert M; Valk PJ; Behre G; Leibundgut EO; Torbett BE; Fey MF; Tschan MP
Br J Haematol; 2013 Mar; 160(6):855-9. PubMed ID: 23252456
[No Abstract] [Full Text] [Related]
32. Down-regulation of Notch-1 expression decreases PU.1-mediated myeloid differentiation signaling in acute myeloid leukemia.
Chen PM; Yen CC; Wang WS; Lin YJ; Chu CJ; Chiou TJ; Liu JH; Yang MH
Int J Oncol; 2008 Jun; 32(6):1335-41. PubMed ID: 18497996
[TBL] [Abstract][Full Text] [Related]
33. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element.
Okuno Y; Huang G; Rosenbauer F; Evans EK; Radomska HS; Iwasaki H; Akashi K; Moreau-Gachelin F; Li Y; Zhang P; Göttgens B; Tenen DG
Mol Cell Biol; 2005 Apr; 25(7):2832-45. PubMed ID: 15767686
[TBL] [Abstract][Full Text] [Related]
34. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
[TBL] [Abstract][Full Text] [Related]
36. Regulation of IL-12 p40 promoter activity in primary human monocytes: roles of NF-kappaB, CCAAT/enhancer-binding protein beta, and PU.1 and identification of a novel repressor element (GA-12) that responds to IL-4 and prostaglandin E(2).
Becker C; Wirtz S; Ma X; Blessing M; Galle PR; Neurath MF
J Immunol; 2001 Sep; 167(5):2608-18. PubMed ID: 11509602
[TBL] [Abstract][Full Text] [Related]
37. ATRA resolves the differentiation block in t(15;17) acute myeloid leukemia by restoring PU.1 expression.
Mueller BU; Pabst T; Fos J; Petkovic V; Fey MF; Asou N; Buergi U; Tenen DG
Blood; 2006 Apr; 107(8):3330-8. PubMed ID: 16352814
[TBL] [Abstract][Full Text] [Related]
38. CLEC5A (MDL-1) is a novel PU.1 transcriptional target during myeloid differentiation.
Batliner J; Mancarelli MM; Jenal M; Reddy VA; Fey MF; Torbett BE; Tschan MP
Mol Immunol; 2011 Jan; 48(4):714-9. PubMed ID: 21094529
[TBL] [Abstract][Full Text] [Related]
39. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site.
Smith MF; Carl VS; Lodie T; Fenton MJ
J Biol Chem; 1998 Sep; 273(37):24272-9. PubMed ID: 9727052
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor PU.1 mediates enhancer-promoter looping that is required for IL-1β eRNA and mRNA transcription in mouse melanoma and macrophage cell lines.
Ha SD; Cho W; DeKoter RP; Kim SO
J Biol Chem; 2019 Nov; 294(46):17487-17500. PubMed ID: 31586032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]